These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35485399)

  • 21. Risk of colorectal cancer and adenomas in the families of patients with adenomas: a population-based study in Utah.
    Tuohy TM; Rowe KG; Mineau GP; Pimentel R; Burt RW; Samadder NJ
    Cancer; 2014 Jan; 120(1):35-42. PubMed ID: 24150925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colorectal Cancer Screening With Repeated Fecal Immunochemical Test Versus Sigmoidoscopy: Baseline Results From a Randomized Trial.
    Randel KR; Schult AL; Botteri E; Hoff G; Bretthauer M; Ursin G; Natvig E; Berstad P; Jørgensen A; Sandvei PK; Olsen ME; Frigstad SO; Darre-Næss O; Norvard ER; Bolstad N; Kørner H; Wibe A; Wensaas KA; de Lange T; Holme Ø
    Gastroenterology; 2021 Mar; 160(4):1085-1096.e5. PubMed ID: 33227280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and cost-effectiveness of fecal immunochemical test versus colonoscopy in colorectal cancer screening: a systematic review and meta-analysis.
    Zhong GC; Sun WP; Wan L; Hu JJ; Hao FB
    Gastrointest Endosc; 2020 Mar; 91(3):684-697.e15. PubMed ID: 31790657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subsequent participation in organized FIT based screening following screen-derived colonoscopy
    Bülow Therkildsen S; Larsen PT; Njor S
    Prev Med Rep; 2023 Apr; 32():102125. PubMed ID: 36816764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of subsequent screening episodes on the positive predictive value for advanced neoplasia and on the distribution of anatomic subsites of colorectal cancer: A population-based study on behalf of the French colorectal cancer screening program.
    Azimafoussé Assogba GF; Jezewski-Serra D; Lastier D; Quintin C; Denis B; Beltzer N; Duport N
    Cancer Epidemiol; 2015 Dec; 39(6):964-71. PubMed ID: 26546750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection rates of adenomas, advanced adenomas, and colorectal cancers among the opportunistic colonoscopy screening population: a single-center, retrospective study.
    Gong Y; Zheng Y; Wu R; Liu M; Li H; Zeng Q
    Chin Med J (Engl); 2023 Jan; 136(2):159-166. PubMed ID: 36692899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sex-specific prevalence of adenomas, advanced adenomas, and colorectal cancer in individuals undergoing screening colonoscopy.
    Ferlitsch M; Reinhart K; Pramhas S; Wiener C; Gal O; Bannert C; Hassler M; Kozbial K; Dunkler D; Trauner M; Weiss W
    JAMA; 2011 Sep; 306(12):1352-8. PubMed ID: 21954479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colonoscopy surveillance following adenoma removal to reduce the risk of colorectal cancer: a retrospective cohort study.
    Cross AJ; Robbins EC; Pack K; Stenson I; Kirby PL; Patel B; Rutter MD; Veitch AM; Saunders BP; Little M; Gray A; Duffy SW; Wooldrage K
    Health Technol Assess; 2022 May; 26(26):1-156. PubMed ID: 35635015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening.
    Grobbee EJ; van der Vlugt M; van Vuuren AJ; Stroobants AK; Mallant-Hent RC; Lansdorp-Vogelaar I; Bossuyt PMM; Kuipers EJ; Dekker E; Spaander MCW
    Clin Gastroenterol Hepatol; 2020 Mar; 18(3):667-675.e1. PubMed ID: 31419575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term risk of colorectal cancer after negative colonoscopy in a Danish gFOBT screening cohort.
    Bjerrum A; Andersen O; Fischer A; Lindebjerg J; Lynge E
    Int J Cancer; 2017 Aug; 141(3):503-511. PubMed ID: 28463410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive Modeling of Colonoscopic Findings in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program.
    Law J; Rajan A; Trieu H; Azizian J; Berry R; Beaven SW; Tabibian JH
    Dig Dis Sci; 2022 Jul; 67(7):2842-2848. PubMed ID: 34350518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colorectal cancer screening with faecal testing, sigmoidoscopy or colonoscopy: a systematic review and network meta-analysis.
    Jodal HC; Helsingen LM; Anderson JC; Lytvyn L; Vandvik PO; Emilsson L
    BMJ Open; 2019 Oct; 9(10):e032773. PubMed ID: 31578199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
    Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
    Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fecal immunochemical test in cancer screening - colonoscopy outcome in FIT positives and negatives.
    Ribbing Wilén H; Blom J; Höijer J; Andersson G; Löwbeer C; Hultcrantz R
    Scand J Gastroenterol; 2019 Mar; 54(3):303-310. PubMed ID: 30907196
    [No Abstract]   [Full Text] [Related]  

  • 36. Fecal immunochemical test in colorectal cancer screening: Colonoscopy findings by different cut-off levels.
    Ribbing Wilén H; Blom J; Höijer J; Hultcrantz R
    J Gastroenterol Hepatol; 2019 Jan; 34(1):103-112. PubMed ID: 29968937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fecal MicroRNA-Based Algorithm Increases Effectiveness of Fecal Immunochemical Test-Based Screening for Colorectal Cancer.
    Duran-Sanchon S; Moreno L; Gómez-Matas J; Augé JM; Serra-Burriel M; Cuatrecasas M; Moreira L; Serradesanferm A; Pozo À; Grau J; Pellisé M; Gironella M; Castells A
    Clin Gastroenterol Hepatol; 2021 Feb; 19(2):323-330.e1. PubMed ID: 32113893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Which adenomas are detected by fecal occult blood testing? A state-wide analysis from Bavaria, Germany.
    Brenner H; Hoffmeister M; Birkner B; Stock C
    Int J Cancer; 2015 Apr; 136(7):1672-9. PubMed ID: 25142576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
    Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
    JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.